Content area
Cell death is a critical process that occurs normally in health and disease. However, its study is limited due to available technologies that only detect very late stages in the process or specific death mechanisms. Here, we report the development of a family of fluorescent biosensors called genetically encoded death indicators (GEDIs). GEDIs specifically detect an intracellular Ca2+ level that cells achieve early in the cell death process and that marks a stage at which cells are irreversibly committed to die. The time-resolved nature of a GEDI delineates a binary demarcation of cell life and death in real time, reformulating the definition of cell death. We demonstrate that GEDIs acutely and accurately report death of rodent and human neurons in vitro, and show that GEDIs enable an automated imaging platform for single cell detection of neuronal death in vivo in zebrafish larvae. With a quantitative pseudo-ratiometric signal, GEDIs facilitate high-throughput analysis of cell death in time-lapse imaging analysis, providing the necessary resolution and scale to identify early factors leading to cell death in studies of neurodegeneration.
Cell death is a critical process in health and disease, yet available markers record later stages of cell death once a cell has already begun to decompose. Here the authors show the use of a genetically encoded calcium indicator that demarcates an irreversible stage of cell death earlier than previously possible.
Details
; Shah, Kevan 1
; Castello, Nicholas 1 ; Chan, Michelle 1 ; Haddad Dominik 2 ; Zak, Doric 3
; Wang, Shijie 4 ; Leks Wiktoria 4 ; Mancini, Jay 4 ; Oza Viral 4 ; Javaherian Ashkan 4 ; Nakamura, Ken 5
; Kokel, David 6 ; Finkbeiner, Steven 7
1 Gladstone Center for Systems and Therapeutics, San Francisco, USA
2 Gladstone Institute of Neurologic Disease, San Francisco, USA
3 Gladstone Institute of Neurologic Disease, San Francisco, USA; University of California, Neuroscience Graduate Program, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
4 Gladstone Center for Systems and Therapeutics, San Francisco, USA (GRID:grid.266102.1)
5 Gladstone Institute of Neurologic Disease, San Francisco, USA (GRID:grid.266102.1); University of California, Biomedical Sciences and Neuroscience Graduate Program, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California, Department of Neurology, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
6 University of California, Department of Physiology, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California, Institute for Neurodegenerative Disease, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
7 Gladstone Center for Systems and Therapeutics, San Francisco, USA (GRID:grid.266102.1); Taube/Koret Center for Neurodegenerative Disease, Gladstone Institutes, San Francisco, USA (GRID:grid.249878.8) (ISNI:0000 0004 0572 7110)